Ampio Pharmaceuticals Inc (AMPE)

0.161 -0.02 (-9.75%) USD  |  NYAM  |  Jun 27, 16:00
0.1621 0.00 (0.00%) After-Hours: 20:00
More

Ampio Pharmaceuticals News

News

Headline
Wire
Time (ET)
Ampio Pharmaceuticals' CEO Mike Martino Issues Letter to Stockholders
Yahoo
06/02 16:30
Ampio's Independent Committee Launches Investigation Related To AP-013 Trial
Yahoo
05/17 11:34
Top Premarket Decliners
MT Newswires
05/17 07:51
Ampio Pharmaceuticals Reports First-Quarter Financial Results
Yahoo
05/16 16:10
Ampio Independent Committee to Conduct Investigation
Yahoo
05/16 16:05
Ampio Pharmaceuticals, Inc. to Hold Conference Call
PR Newswire
04/27 16:45
Sector Update: Health Care Stocks Struggle in Weakening Thursday Markets
MT Newswires
04/21 15:16
Sector Update: Health Care Stocks Underwater in Thursday Trading
MT Newswires
04/21 12:56
Wall Street Set for Gains as Corporate Earnings Lift Sentiment; Powell Comments Eyed
MT Newswires
04/21 09:19
Top Premarket Decliners
MT Newswires
04/21 07:55
Ampio stock slumps 33% as FDA disagrees with changes to trial, unblinding data for pain drug Ampion
SA Breaking News
04/21 06:03
AMPIO PROVIDES REGULATORY UPDATE
PR Newswire
04/20 17:49
New Strong Sell Stocks for April 7th
Yahoo
04/07 07:04
Ampio Pharmaceuticals Reports Fourth-Quarter and Full-Year 2021 Financial Results and Operational Highlights
PR Newswire
03/29 16:10
Earnings Reaction History: Ampio Pharmaceuticals Inc, 75.0% Follow-Through Indicator, 10.8% Sensitive
MT Newswires
03/29 12:06
Thinking about buying stock in Mullen Automotive, Ampio Pharmaceuticals, AMC Entertainment, Hycroft Mining, or IQIYI?
PR Newswire
03/24 11:00
--Alliance Global Partners Initiates Ampio Pharmaceuticals at Buy, Sets Price Target at $4.50/Share
MT Newswires
03/24 08:03
After Hours Watch List Scorecard: AMPE, IOT, SNOW
MT Newswires
03/03 17:31
MT Newswires After Hours Watch List: AMPE, IOT, SNOW
MT Newswires
03/02 17:44
Ampio Says Late-Stage Data Analysis Show Ampion Significantly Reduces Pain From Severe Osteoarthritis of the Knee
MT Newswires
03/02 16:52
Ampio Pharmaceuticals, Inc. Releases Positive Phase 3 Data Analysis for Ampion™ Targeting Severe Osteoarthritis of the Knee (OAK)
PR Newswire
03/02 16:05
Ampio Expands Board of Directors with Addition of Elizabeth Varki Jobes
PR Newswire
02/10 09:00
Ampio Pharmaceuticals Presents Corporate Overview at H.C. Wainwright Bioconnect Conference
PR Newswire
01/06 08:30
Ampio Pharmaceuticals' CEO Mike Martino Issues Letter to Stockholders
PR Newswire
12/16 08:35
Ampio Pharmaceuticals to Host Business Update Call with Chairman and CEO Mike Martino on Wednesday, Dec. 1
PR Newswire
11/29 16:01
Ampio Pharmaceuticals Chief Executive Mike Macaluso Takes Medical Leave; Interim Replacement Named
MT Newswires
11/22 10:50
Ampio Pharmaceuticals CEO Mike Macaluso to take one-year leave of absence
SA Breaking News
11/22 09:45
Board Member Michael Martino to Become Interim Chairman and CEO of Ampio Pharmaceuticals, Mike Macaluso to Take Medical Leave
PR Newswire
11/22 09:15
Earnings Reaction History: Ampio Pharmaceuticals Inc, 66.7% Follow-Through Indicator, 11.1% Sensitive
MT Newswires
11/10 12:06
Ampio Pharmaceuticals Strengthens Management Team and Board of Directors
PR Newswire
10/13 09:15
Ampio Wins India Regulatory Approval to Start Mid-Stage Study of Inhaled Ampion for COVID-19-Related Respiratory Distress
MT Newswires
09/21 14:51
Ampio Pharmaceuticals Receives Approval from the Drugs Controller General of India (DCGI) to Commence AP-019 Phase II Study in India
PR Newswire
09/21 09:15
Sector Update: Health Care Stocks Pare Early Gains As Cyclicals Dominate Afternoon Trade
MT Newswires
09/15 15:52
YY, NNVC and REKR among mid-day movers
SA Breaking News
09/15 13:41
Sector Update: Health Care Stocks Adding to Recent Intra-Day Highs
MT Newswires
09/15 13:23
Ampio Pharma Says Drug Candidate Reduces Pain in Late-Stage Knee Osteoarthritis Trial; Stock Jumps
MT Newswires
09/15 11:12
Ampio Pharmaceuticals, 180 Life Sciences leads healthcare gainers; Nuwellis, Berkeley Lights among major losers
SA Breaking News
09/15 11:08
Ampio Pharmaceuticals Announces Top-line Results from AP-013 Phase III Study of Ampion in Adult Patients Suffering from Severe Osteoarthritis of the Knee (OAK)
PR Newswire
09/15 09:15
Ampio Pharmaceuticals Says New Research Cites Ampion as Dexamethasone Alternative
MT Newswires
08/13 10:55
Ampio Pharmaceuticals Announces Important New Research Manuscript on Anti-Inflammatory Mode of Action
PR Newswire
08/13 09:15
Thinking about buying stock in Ampio Pharmaceuticals, Stratasys, Zymergen, Himax Technologies, or Genius Sports?
PR Newswire
08/05 09:31
Ampio Pharmaceuticals EPS in-line
SA Breaking News
08/04 16:10
Ampio Pharmaceuticals, Inc. Announces Second Quarter 2021 Financial Results and Provides Corporate Update
PR Newswire
08/04 16:01
Ampio Pharmaceuticals to Present at the American College of Toxicology 42nd Annual Meeting
PR Newswire
07/29 09:15
Ampio Pharmaceuticals to Present at the 14th International Congress on Systemic Lupus Erythematosus (LUPUS 2021) & 6th International Congress on Controversies in Rheumatology and Autoimmunity (CORA)
PR Newswire
07/28 09:15
Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 Second Quarter Financial Results and Provide Corporate Business Update
PR Newswire
07/14 09:15
Ampio Pharmaceuticals Announces Patient Randomization and Dosing in AP-019 Phase II Study of Inhaled Ampion in COVID-19 Respiratory Distress
PR Newswire
06/25 09:15
Ampio to Join Russell 2000, 3000 Indexes
MT Newswires
06/18 10:06
Ampio Pharmaceuticals, Inc. to Join the Russell 2000® Index and Russell 3000® Index
PR Newswire
06/18 09:15
Ampio Pharmaceuticals Says New Data Shows Efficacy of Ampion in Patients With Severe Osteoarthritis of the Knee
MT Newswires
06/17 15:25
Ampio highlights integrated data from Ampion osteoarthritis of the knee trials
SA Breaking News
06/17 09:58
Ampio Provides Update on Osteoarthritis of the Knee (OAK) Program, Reiterates Compelling Data in Earlier Phase III Trials of Ampion in Severe OAK
PR Newswire
06/17 09:15
Thinking about buying stock in Eloxx Pharmaceuticals, Sio Gene Therapies, Ampio Pharmaceuticals, Applied Genetic Technologies, or Cyclo Therapeutics?
PR Newswire
06/15 09:31
Ampio Pharmaceuticals Gets Regulatory Approval to Expand Enrollment of Mid-Stage Study of Ampion to India
MT Newswires
06/15 06:50
Ampio Pharma stock surge 33% on AP-019 Phase II study expansion to India
SA Breaking News
06/15 06:27
Ampio Pharmaceuticals Receives Approval to Expand Enrollment of its AP-019 Phase II Study to India
PR Newswire
06/15 06:15
Ampio Pharmaceuticals to Present at the 2021 International Society for Pharmaceutical Engineers Annual Meeting and Expo
PR Newswire
06/14 06:15
Ampio Pharmaceuticals to Participate in the Alliance Global Partners' Virtual Summer Healthcare Symposium
PR Newswire
06/11 09:15
Ampio Pharmaceuticals to Present Poster at the International Society for Aerosols in Medicine (ISAM) 23rd International Congress
PR Newswire
05/21 09:15
Ampio Wins Investigational Review Board Approval for Phase 1 Long Covid-19 Trial
MT Newswires
05/10 11:07
Ampio Pharmaceuticals Receives Investigational Review Board Approval for its Phase I Long COVID-19 Trial (AP-018)
PR Newswire
05/10 09:15
Ampio Pharmaceuticals EPS in-line
SA Breaking News
05/05 16:09
Ampio Pharmaceuticals, Inc. Reports First Quarter 2021 Financial Results and Provides Business Update
PR Newswire
05/05 16:01
Ampio Gets FDA Positive Response For Knee Osteoarthritis Treatment Phase III Trial
MT Newswires
04/27 15:02
Ampio Pharma's Ampion reduces mortality nearly 80% in COVID-19
SA Breaking News
04/27 09:36
Ampio Pharmaceuticals Provides Updates on Clinical Programs for Ampion™ in Osteoarthritis and COVID-19
PR Newswire
04/27 09:15
Ampion™ Reduces All-cause Mortality in COVID-19 Respiratory Distress by Nearly 80%
PR Newswire
04/27 09:15
Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 First Quarter Financial Results and Provide Corporate Business Update
PR Newswire
04/21 09:15
Research Shows Ampion™ Gene Regulation Mimics the Anti-Inflammatory Effects of Steroids, but without Adverse Effects
PR Newswire
04/19 09:15
Ampio Pharmaceuticals Says Preclinical Data Show Potential of Ampion to Treat Severe Immune Reaction in COVID-19
MT Newswires
04/06 10:38
Ampio posts encouraging results from Ampion COVID-19 pre-clinical study
SA Breaking News
04/06 09:30
Ampio Pharmaceuticals' Study Shows Ampion Inhibits a Key Inflammatory Pathway in COVID-19 and Lupus Nephritis
PR Newswire
04/06 09:15
Ampio Pharmaceuticals to Present at the International Society for Aerosols in Medicine (ISAM) 23rd International Congress
PR Newswire
03/29 09:15
Ampio Pharmaceuticals to Present at Benzinga Biotech Small Cap Conference
PR Newswire
03/19 09:15
Ampio surges 7.5% on phase 1 data for COVID-19 respiratory treatment
SA Breaking News
03/16 10:01
Ampio Pharmaceuticals posts early positive results in inhaled Ampion COVID-19 trial
SA Breaking News
03/16 09:57
Ampio Pharmaceuticals Details Early Positive Results for Inhaled Ampion in COVID-19 Respiratory Distress
PR Newswire
03/16 09:15
Ampio Pharmaceuticals to Participate in the 33rd Annual Virtual ROTH Conference on March 15-17, 2021
PR Newswire
03/10 16:01
Sector Update: Health Care Stocks Slipping This Afternoon
MT Newswires
03/04 15:47
Five Prime Therapeutics leads healthcare gainers; BioVie, Schrodinger maong major losers
SA Breaking News
03/04 10:55
Ampio Pharma Narrows Q4 Loss vs. Last Year, Sees Enough Funds Till Q1 Next Year
MT Newswires
03/03 16:09
Ampio Pharmaceuticals, Inc. Reports Fourth Quarter 2020 Financial Results and Provides Business Update
PR Newswire
03/03 16:01
Ampio Pharmaceuticals to Present at the H.C. Wainwright Global Life Sciences Conference
PR Newswire
03/03 09:15
Thinking about buying stock in Powerbridge Technologies, BioCryst Pharma, Oramed Pharma, Ampio Pharma, or Plus Therapeutics?
PR Newswire
02/26 09:31
Ampio Pharmaceuticals, Inc. to Report Annual 2020 Financial Results and Provide Corporate Business Update
PR Newswire
02/24 09:15
Ampio Pharma Adds New Hospitals to Expand Ampion Inhalation Drug Trial in COVID-19 Patients
MT Newswires
02/23 13:23
Ampio adds new Ampion COVID-19 trial sites
SA Breaking News
02/23 09:41
Ampio Brings New Hospitals Online in Trial for Inhalation Treatment of COVID-19 with Ampion
PR Newswire
02/23 09:15
Thinking about buying stock in Ampio Pharmaceuticals, Motus GI, Phio Pharmaceuticals, Novan, or Oncolytics Biotech?
PR Newswire
02/18 09:31
Ampio Pharmaceuticals, Inc. to Present at Upcoming Investor Conference
PR Newswire
02/16 09:15
Ampio posts early positive data from phase 1 COVID-19 respiratory distress trial
SA Breaking News
02/01 09:27
Ampio Announces Early Positive Data in Phase 1 Trial of Inhaled Ampion in COVID-19 Respiratory Distress
PR Newswire
02/01 09:15
Ampio Pharma updates on phase I trial enrolment for COVID-19 ampion study
SA Breaking News
01/14 16:09
Ampio Says Phase 1 Trial of COVID-19 Inhalation Treatment is 55% Enrolled
MT Newswires
01/14 11:25
Ampio Pharmaceuticals Ongoing Phase I Clinical Trial for Inhalation Treatment of COVID-19 with Ampion is 55% Enrolled
PR Newswire
01/14 09:15
Ampio Begins Study of IV-Administered Ampion for Covid-19 in Hospital, Out-Patient Settings; Phase I Study of Inhaled Ampion Shows No Drug-Related Adverse Events
MT Newswires
01/04 15:08
Ampion updates on COVID-19 trial progress
SA Breaking News
01/04 10:00
Ampio Provides Update on Clinical Trials for Ampion™ Treatment of COVID-19 Patients
PR Newswire
01/04 09:15
Bionano Genomics and Ampio Pharmaceuticals among healthcare gainers; Histogen leads losers
SA Breaking News
12/31 11:29
Thinking about buying stock in BioNano Genomics, Ampio Pharmaceuticals, TRACON Pharmaceuticals, eMagin Corp, or Matinas BioPharma?
PR Newswire
12/31 08:30
BILI, BNGO among premarket gainers
SA Breaking News
12/31 08:22
Bionano Genomics, DermTech leads healthcare gainers; Regional Health Properties, Osmotica Pharmaceuticals among major losers
SA Breaking News
12/30 10:59
Ampio Pharmaceuticals Slips as COVID-19 Impacts Phase 3 Trial for Ampion
MT Newswires
12/29 10:16
Ampio cleared to complete Phase 3 study for osteoarthritis
SA Breaking News
12/29 09:51
Ampio Receives feedback from the FDA on Ampio's Proposed Modifications to the special protocol assessment for Ampion treatment of severe Osteoarthritis of the knee
PR Newswire
12/29 09:15
Avinger, Neoleukin Therapeutics leads healthcare gainers; Jaguar Health, Ocugen among major losers
SA Breaking News
12/24 10:28
Nano Dimension (NNDM), Triterras (TRIT), MicroVision (MVIS) and Bridgetown Holdings (BTWN) among premarket gainers
SA Breaking News
12/24 08:21
Thinking about buying stock in CASI Pharmaceuticals, FuelCell Energy, Ampio Pharmaceuticals, Mohawk Group, or Perion Network?
PR Newswire
12/23 09:31
SUPN, CLNE, MGNI and LIZI among premarket gainers
SA Breaking News
12/23 08:43
Thinking about buying stock in CNS Pharmaceuticals, DermTech, Ampio Pharmaceuticals, Surface Oncology, or Amyris?
PR Newswire
12/18 08:30
Healthcare tops premarket gainers list
SA Breaking News
12/18 08:21
Ampio Pharms's IV Ampion demonstrates safety in COVID-19 study
SA Breaking News
12/17 14:37
Ampion Demonstrates Safety In COVID-19 Patients And Initiates Global Clinical Trial For Intravenous Ampion
PR Newswire
12/17 09:15
Thinking about buying stock in Inseego Corp, Ampio Pharmaceuticals, Marathon Patent Group, Regulus Therapeutics, or BioCryst Pharmaceuticals?
PR Newswire
12/14 09:31
ALXN, BEP, DBX and NWG among premarket gainers
SA Breaking News
12/14 08:24
Thinking about buying stock in Nantkwest, Ampio Pharmaceuticals, Arbutus Biopharma, Xeris Pharmaceuticals, or iBio Inc?
PR Newswire
12/11 09:31
DIS, RIDE among premarket gainers
SA Breaking News
12/11 08:19
Ampio inks research pact explore new indications for Ampion
SA Breaking News
12/10 15:10
Ampio Enters into Collaborative Research Agreements to Explore Additional Clinical Indications for its Immunomodulatory Drug, Ampion
PR Newswire
12/10 09:15
Thinking about buying stock in Pfizer, Ampio Pharmaceuticals, Aerpio Pharmaceuticals, Electrameccanica Vehicles, or United Airlines?
PR Newswire
12/09 09:31
SRNE, QS among premarket gainers
SA Breaking News
12/09 08:42
Ampio Pharmaceuticals, Inc. to Host its Annual Meeting on December 12, 2020
PR Newswire
12/08 09:15
SFIX, AR among premarket gainers
SA Breaking News
12/08 08:25
Ampio Pharmaceuticals' Phase 1 Trial of Inhaled Ampion in COVID-19 Patients Advances to Full Open Enrollment
MT Newswires
12/02 10:47
Ampio Pharmaceuticals to complete enrollment in early-stage with inhaled Ampion in COVID-19 patients
SA Breaking News
12/02 10:42
Ampio's Phase I Study For Inhaled Ampion Advances To Completing Enrollment Of COVID-19 Patients With Respiratory Distress
PR Newswire
12/02 09:15
Ampio updates on Phase 1 study with inhaled Ampion in COVID-19 patients
SA Breaking News
11/25 09:50
Ampio Updates Regulatory and Clinical Trial Events
PR Newswire
11/25 09:15
Ampio's Phase I Study for Inhaled Ampion Advances to 3rd Group of COVID-19 Patients with Respiratory Distress
PR Newswire
11/17 09:15
Ampio's Phase I Study For Inhaled Ampion Advances To 2nd Group Of COVID-19 Patients With Respiratory Distress
PR Newswire
11/10 16:01
Ampio Pharmaceuticals, Inc. Provides Business Update and Reports Third Quarter 2020 Financial Results
PR Newswire
11/05 15:45
Ampio Pharmaceuticals, Inc. to Host Conference Call on November 5th
PR Newswire
11/02 09:15
Ampio Pharmaceuticals Starts Phase 1 Ampion Trial in COVID-19 Patients
MT Newswires
10/28 10:34
Ampio initiates early-stage study with inhaled Ampion in COVID-19 patients
SA Breaking News
10/28 07:56
Ampio Begins Phase 1 Clinical Trial of Inhaled Ampion For COVID-19 Patients With Respiratory Distress
PR Newswire
10/28 07:30
Ampio Pharmaceuticals, Inc. to Present at the ROTH Capital Healthcare Event "COVID-19 Therapeutics in Development"
PR Newswire
10/27 09:15
Ampio Presents at Roth Capital Partners 2020 MedTech Innovation Forum Focusing on COVID-19 Clinical Trial Activities
PR Newswire
10/26 09:15
Ampio Publication Reports Beneficial Effects of Ampion on Important Transcription Factors in Inflammation
PR Newswire
10/08 09:15
AMPE, TSLA among premarket losers
SA Breaking News
09/22 08:23
Thinking about buying stock in Onconova Therapeutics, Norwegian Cruise Line, Ampio Pharmaceuticals, Delta Air Lines, or Plug Power?
PR Newswire
09/21 10:45
Ampio Gets FDA Clearance to Proceed With Trial of COVID-19 Inhalation Therapy
MT Newswires
09/21 10:31
Ampio Pharma on go with inhaled Ampion study in COVID-19
SA Breaking News
09/21 09:27
FDA Grants IND and Approves Clinical Trial Protocol of Inhaled Ampion for COVID-19 Patients with Respiratory Distress
PR Newswire
09/21 09:15
Ampion Phase I COVID-19 Patient Trial Results Featured on FOX News (Video)
PR Newswire
09/14 09:15
Ampio Pharmaceuticals Reports Positive Results for COVID-19 Treatment
MT Newswires
09/09 10:14
Ampio's COVID-19 treatment shows positive effect in early-stage study
SA Breaking News
09/09 10:10
Ampio Reports Positive Results for Ampion Treatment in COVID-19 Patients
PR Newswire
09/09 09:15
Ampio Pharmaceuticals Completes Enrollment for Phase 1 Trial of Intravenous COVID-19 Treatment
MT Newswires
09/04 10:14
Ampio completes enrollment in study of Ampion for COVID-19
SA Breaking News
09/04 10:06
Ampio Announces Enrollment Completion for Intravenous ("IV") COVID-19 Clinical Trial & Provides Update on Osteoarthritis of the Knee ("OAK") Clinical Trial
PR Newswire
09/04 09:15
Ampio Provides Update on COVID-19 Clinical Trial Activities
PR Newswire
08/19 08:00
Thinking about buying stock in Sogou Inc, Xperi Holding Corp, Ampio Pharmaceuticals, Heat Biologics, or Arbutus Biopharma?
PR Newswire
07/27 09:31
Ampio Pharma Enrolls Patients for Early-Stage COVID-19 Program - Stock Rises 12%
MT Newswires
07/23 15:53
Ampio Pharma launches early-stage study of Ampion in COVID-19
SA Breaking News
07/23 09:19
Ampio Pharma on go with Ampion study in COVID-19 program
SA Breaking News
07/23 09:19
Ampio Starts Patient Enrollment in its Ampion COVID-19 Program
PR Newswire
07/23 08:00
Ampio Reports a Publication on the Potential Benefits of Ampion for Treatment of a New COVID-19 related Syndrome
PR Newswire
07/20 08:00
Thinking about buying stock in Seanergy Maritime, Delta Air Lines, TOP Ships, Microsoft, or Ampio Pharmaceuticals?
PR Newswire
06/19 10:35
Ampio Pharma (+25%) on go with study of Ampion in COVID-19
SA Breaking News
06/19 10:08
Wall Street Points to Positive Open on Hopes of Quick Economic Rebound
MT Newswires
06/19 09:01
Ampio Pharmaceuticals to Start Human Testing of Investigational COVID-19 Treatment Ampion
MT Newswires
06/19 08:44
Ampio to Start First Clinical Trial in COVID-19 Program
PR Newswire
06/19 08:00
Ampio Pharma Files Applications With FDA for Ampion as Potential Treatment for COVID-19
MT Newswires
05/22 14:39
Wall Street Wavers Prebell As US-China Tensions Escalate
MT Newswires
05/22 09:06
Ampio to advance Ampion for potential treatment of COVID-19
SA Breaking News
05/22 08:28
Ampio Provides Update on COVID-19 Program
PR Newswire
05/22 08:00
Ampio Reports Acceptance of Publication on the Potential Benefits of Nebulized Ampion™ for COVID-19 Patients
PR Newswire
05/11 08:00
Ampio Pharmaceuticals Files for $100 Million Shelf
MT Newswires
04/17 10:37
Ampio files for mixed shelf
SA Breaking News
04/17 06:35
Ampio Pharmaceutical's Application to the FDA for a Clinical Study of Ampion™ to Treat COVID-19 Induced Acute Respiratory Distress Syndrome (ARDS) featured in FOX News (VIDEO)
PR Newswire
04/02 09:00
Ampio Pharmaceuticals Temporarily Suspends Patient Enrollment in Study of Osteoarthritis Treatment
MT Newswires
03/24 07:46
Ampio down 5% premarket after discontinuing patient enrollment in late-stage AP-013 trial amid COVID-19
SA Breaking News
03/24 07:37
Ampio Suspends Patient Enrollment in its Phase 3 Study of Ampion for Severe Osteoarthritis of the Knee and Explores Other Options to Complete Trial
PR Newswire
03/24 07:00
Ampio to study nebulized Ampion as a treatment for COVID-19
SA Breaking News
03/24 06:51
Ampio is Preparing an Expanded Access FDA protocol to Study Nebulized Ampion as a Treatment for Moderate to Severe Acute Respiratory Distress Syndrome Associated with COVID-19
PR Newswire
03/24 06:30
Ampio Provides Corporate Update
PR Newswire
02/21 06:30
Barclays sees 21% upside in J&J in premarket analyst action
SA Breaking News
12/19 07:49
--Analyst Actions: Roth Capital Initiates Coverage on Ampio Pharmaceuticals With Buy Rating, $4 Price Target
MT Newswires
12/19 07:08
--Analyst Actions: Roth Initiates Ampio Pharmaceuticals With Buy Rating, $4 Price Target
MT Newswires
12/18 16:06
Ampio Pharmaceuticals' Late-Stage Study of Knee Osteoarthritis Pain Drug Reaches 33% Completion
MT Newswires
12/04 09:33
Ampio Provides Update on AP-013 Phase III Clinical Trial and Annual Meeting Conference Call Number
PR Newswire
12/04 08:30
Ampio Pharmaceuticals Asked for Info as SEC Conducts Trade Probe
MT Newswires
11/08 06:42
Ampio Provides Update on Continued Progress of AP-013 Phase III Clinical Trial and Manufacturing Facility
PR Newswire
10/10 08:30
Ampio Retains Legal Counsel for Transaction Advisory Committee
PR Newswire
09/18 08:30
Ampio Pharmaceuticals Says 423 Patients Injected With Ampion in Study to Treat Knee Pain
MT Newswires
09/17 13:46
Ampio Pharma advancing late-stage study AP-003-A
SA Breaking News
09/17 09:08
Ampio Pharmaceuticals Updates Progress of SPA Clinical Trial
PR Newswire
09/17 08:30
Ampio to explore strategic alternatives; shares up 3%
SA Breaking News
08/22 10:08
Ampio Pharmaceuticals Hires Financial Advisor, Names Transaction Advisory Committee Members
MT Newswires
08/22 09:21
Ampio Pharmaceuticals Retains Financial Advisor and Appoints Transaction Advisory Committee
PR Newswire
08/22 08:30
Ampio Pharmaceuticals Updates Progress of SPA Clinical Trial
PR Newswire
07/25 08:30
Ampio Appoints Moss Adams LLP as the Company's New Independent Auditor
PR Newswire
07/11 08:30
New finance chief at Ampio
SA Breaking News
07/10 09:24
Ampio Appoints Dan Stokely as the Company's new Chief Financial Officer
PR Newswire
07/10 08:30
MT Newswires After-Hours News Movers
MT Newswires
06/19 17:42
Ampio Pharmaceuticals Raises $12.0 Mln from Public Offering
MT Newswires
06/19 16:04
Ampio Pharmaceuticals Announces Closing of $12 Million Public Offering
PR Newswire
06/19 16:01
Close Update: US Stocks Start the Week Slightly Higher Ahead of Fed Meeting
MT Newswires
06/17 16:33
Mid-Day Update: US Stocks Advance Monday Led by Nasdaq as Investors Look Ahead to Fed Meeting
MT Newswires
06/17 12:47
Wall Street Sees Cautiously Higher Open Ahead of Fed Meeting
MT Newswires
06/17 09:05
Ampio down 31% premarket on pricing stock offering
SA Breaking News
06/17 08:34
Ampio Pharmaceuticals Slides 31.5% - Prices 25.32 Mln Shares at $0.40 Each in Offering
MT Newswires
06/17 08:25
Ampio Pharmaceuticals Announces Pricing of Public Offering
PR Newswire
06/17 08:16
Ampio slides 22% after proposing stock offering
SA Breaking News
06/14 16:16
Ampio Proposes Public Offering of Common Stock; Shares Slump After-Hours
MT Newswires
06/14 16:07
Ampio Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
PR Newswire
06/14 16:01
Ampio Receives FDA Protocol Approval for Trial of Ampion Injection in Osteoarthritis Treatment
MT Newswires
06/14 08:00
Ampio moves forward with Ampion protocol
SA Breaking News
06/14 07:40
Ampio Regulatory and Clinical Update
PR Newswire
06/14 07:30
Ampio Pharmaceuticals CFO Thomas Chilcott Resigns
MT Newswires
06/14 06:54
Ampio finance chief bids adieu
SA Breaking News
06/13 16:46
Ampio Clinical, Regulatory and Corporate Update
PR Newswire
05/22 08:30
Ampio Pharmaceuticals to Wait for FDA's Concurrence on Trial Design Before Starting Confirmatory Osteoarthritis Study
MT Newswires
04/29 14:27
Ampio not quite there with confirmatory study of Ampion; shares down 5% premarket
SA Breaking News
04/29 08:25
Ampio Pharmaceuticals Provides Regulatory Update
PR Newswire
04/29 08:00
Ampio Pharmaceuticals Provides Corporate Update
PR Newswire
03/26 19:34
Ampio Updates Regulatory Status for Ampion
PR Newswire
03/06 08:30
Research Report Identifies Wolverine World Wide, Viking Therapeutics, Ampio Pharmaceuticals, ArcelorMittal, Delphi Technologies, and Unit with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
Globe Newswire
02/25 07:40
Ampio Updates Status of Pivotal Clinical Trial of Ampion to be Carried Out Under a SPA
PR Newswire
02/06 08:30
Sector Update: Health Care Stocks Little Changed Mid-Day Thursday; Biotech Shares Tumble
MT Newswires
12/13 13:45
Sector Update: Health Care Stocks Mostly Flat Pre-Bell Thursday
MT Newswires
12/13 09:09
Ampio Pharmaceuticals Provides Regulatory Update on Ampion
MT Newswires
12/13 07:31
FDA requires additional study of Ampio Pharma's Ampion to support marketing application; shares down 11% premarket
SA Breaking News
12/13 07:10
Ampio Updates Regulatory Status for Ampion
PR Newswire
12/13 06:00
U.S. regulatory decision approaches for Ampio Pharma's Ampion
SA Breaking News
11/26 08:46
Ampio Updates Regulatory and Publication status for Ampion™
PR Newswire
11/26 08:30
Ampio Updates Regulatory and Clinical Status for Ampion™
PR Newswire
11/07 08:30
Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Ampio Pharmaceuticals, Inc. (AMPE) and Encourages AMPE Investors to Contact the Firm
Globe Newswire
10/30 12:23
Factors of Influence in 2018, Key Indicators and Opportunity within Intersect ENT, Akari Therapeutics, Ampio Pharmaceuticals, Virtusa, Umpqua, and Hamilton Lane — New Research Emphasizes Economic Growth
Globe Newswire
10/25 08:55
CLASS ACTION UPDATE for AMPE, ALNY and CHGG: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Globe Newswire
10/24 12:00
Deadline Alert: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ampio Pharmaceuticals, Inc.
Globe Newswire
10/23 16:33
SHAREHOLDER ALERT: AMPE LCI PZZA SKX PM USAT COCP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
Globe Newswire
10/23 15:55
WEDNESDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Globe Newswire
10/23 11:55
FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Ampio Pharmaceuticals, Inc. (AMPE) and Lead Plaintiff Deadline – October 24, 2018
Globe Newswire
10/23 10:00
CLASS ACTION UPDATE for AMPE, ALNY and HTHT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Globe Newswire
10/22 11:40
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Pinduoduo, CV Sciences, and Ampio and Encourages Investors to Contact the Firm
Globe Newswire
10/21 18:00
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ampio Pharmaceuticals, Inc. to Contact The Firm
Business Wire
10/21 14:00
SHAREHOLDER ALERT: AMPE NVRO PZZA OPK QRTEA MCHP COCP TGTX CPB TRVN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
Globe Newswire
10/21 11:00
AMPE OCT. 24 ALERT: Rosen Law Firm Reminds Ampio Pharmaceuticals, Inc. Investors of Important Deadline in First Filed Case Commenced by Firm – AMPE
Globe Newswire
10/20 07:00
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ampio Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – AMPE
Globe Newswire
10/19 18:26
Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Ampio Pharmaceuticals, Inc.
Globe Newswire
10/19 17:05
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ampio Pharmaceuticals, Inc. To Contact The Firm
Globe Newswire
10/19 17:00
Ampio October 24th Investor Deadline: Bernstein Liebhard LLP Reminds Investors of the Important Upcoming Deadline in the Shareholder Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. - AMPE
Globe Newswire
10/19 13:24
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PDD, AMPE, NVRO, PZZA and TRCO
Globe Newswire
10/19 12:01
CLASS ACTION UPDATE for AMPE, NVRO and LOGM: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Globe Newswire
10/18 11:31
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AMPE, NVRO, LCI, LOGM and HTHT
Globe Newswire
10/17 12:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ampio, Lannett, and Papa John’s and Encourages Investors to Contact the Firm
Globe Newswire
10/16 19:46
CLASS ACTION UPDATE for AMPE, NVRO and LCI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Globe Newswire
10/16 11:45
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Ampio Pharmaceuticals, Inc. (AMPE) and Lead Plaintiff Deadline – October 24, 2018
Globe Newswire
10/16 10:00
SHAREHOLDER ALERT: PDD AMPE MCHP MGTI HAS ADNT TRVN HTHT SFIX GOOG: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
Globe Newswire
10/14 10:00